Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats
- PMID: 11474483
- DOI: 10.1053/meta.2001.24868
Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats
Abstract
We previously reported that long-term treatment of Zucker diabetic fatty (ZDF) rats with the selective beta(3) agonist CL-316243 normalizes glycemia, decreases plasma free fatty acids (FFA) concentration, improves insulin responsiveness, and increases glucose uptake, not only in brown and white adipose tissues, but also in skeletal muscles. Because muscles do not express typical beta(3) adrenoceptors, we postulated that the muscle effect was indirect and that it was possibly mediated by an activation of the glucose-fatty acid cycle. To test this hypothesis, we investigated the effects of Acipimox, a potent inhibitor of lipolysis in adipose tissue. Similar to CL-316243, Acipimox (150 mg/kg orally) markedly decreased plasma FFA, glucose, and insulin concentrations and improved glucose tolerance while reducing the insulin response in obese (350 to 400 g) ZDF rats. Plasma FFA concentrations were significantly correlated with plasma glucose and insulin concentrations (r =.72 and.83, respectively; P <.01), indicating strong metabolic relationships between these parameters. Euglycemic-hyperinsulinemic clamps combined with the 2-[(3)H]deoxyglucose method revealed that Acipimox markedly improved insulin responsiveness and significantly increased glucose uptake (Rg') in the diaphragm, the heart, and various skeletal muscles. Unlike CL-316243, Acipimox did not increase glucose use in brown or white adipose tissues. This selectivity shows that it is possible to improve diabetes in obese ZDF rats without necessarily stimulating thermogenesis in adipose tissues. Thus, decreasing plasma FFA with 2 drugs (Acipimox or CL-316243) that act via different mechanisms (acute inhibition of lipolysis or chronic stimulation of FFA oxidation) is associated with increased glucose uptake in muscles and enhanced insulin responsiveness. These observations support the hypothesis that CL-316243 may indirectly stimulate glucose uptake in muscles of type II diabetic rats by first stimulating brown adipose tissue (increasing uncoupling protein content and fatty acid oxidation) and progressively decreasing the levels of circulating FFA, resulting in activation of the glucose-fatty acid cycle or other mechanisms regulating insulin responsiveness in skeletal muscles.
Copyright 2001 by W.B. Saunders Company
Similar articles
-
Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.Diabetes. 2005 Nov;54(11):3148-53. doi: 10.2337/diabetes.54.11.3148. Diabetes. 2005. PMID: 16249438 Clinical Trial.
-
Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.Diabetes Metab. 1999 Mar;25(1):11-21. Diabetes Metab. 1999. PMID: 10335419 Review.
-
Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats.Am J Physiol. 1998 May;274(5):R1212-9. doi: 10.1152/ajpregu.1998.274.5.R1212. Am J Physiol. 1998. PMID: 9644032
-
CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats.Diabetes. 1997 Aug;46(8):1257-63. doi: 10.2337/diab.46.8.1257. Diabetes. 1997. PMID: 9231648
-
Rationale and hurdles of inhibitors of hepatic gluconeogenesis in treatment of diabetes mellitus.Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S195-200. doi: 10.1016/0168-8227(95)01079-s. Diabetes Res Clin Pract. 1995. PMID: 8529514 Review.
Cited by
-
Fuziline Ameliorates Glucose and Lipid Metabolism by Activating Beta Adrenergic Receptors to Stimulate Thermogenesis.Int J Mol Sci. 2023 May 6;24(9):8362. doi: 10.3390/ijms24098362. Int J Mol Sci. 2023. PMID: 37176069 Free PMC article.
-
Albumin knockout mice exhibit reduced plasma free fatty acid concentration and enhanced insulin sensitivity.Physiol Rep. 2022 Mar;10(5):e15161. doi: 10.14814/phy2.15161. Physiol Rep. 2022. PMID: 35238481 Free PMC article.
-
Adipose Lipolysis Regulates Cardiac Glucose Uptake and Function in Mice under Cold Stress.Int J Mol Sci. 2021 Dec 12;22(24):13361. doi: 10.3390/ijms222413361. Int J Mol Sci. 2021. PMID: 34948160 Free PMC article.
-
Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease.Nutrients. 2021 Jul 28;13(8):2590. doi: 10.3390/nu13082590. Nutrients. 2021. PMID: 34444750 Free PMC article. Review.
-
Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice.Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):12158-12163. doi: 10.1073/pnas.1808855115. Epub 2018 Nov 14. Proc Natl Acad Sci U S A. 2018. PMID: 30429322 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical